10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Developmental milestones in type I spinal muscular atrophy

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Highlights

          • This paper reports patterns of natural progression in type I SMA.

          • The HINE is used to capture motor developmental milestones in SMA.

          • Motor developmental milestones are rarely acquired in type I SMA infants.

          Abstract

          The aim of this retrospective multicentric study was to assess developmental milestones longitudinally in type I SMA infants using the Hammersmith Infant Neurological Examination. Thirty-three type I SMA infants, who classically do not achieve the ability to sit unsupported, were included in the study. Our results confirmed that all patients had a score of 0 out of a scale of 4 on items assessing sitting, rolling, crawling, standing or walking. A score of more than 0 was only achieved in three items: head control (n = 13), kicking (n = 15) and hand grasp (n = 18). In these items, the maximal score achieved was 1 out of a scale of 4, indicating only partial achievement of the milestone. Infants with symptom onset after 6 months of age had longer preservation of a score of 1 when compared to those with onset before 6 months of age. Our results suggest that even when current standards of care are applied, developmental milestones are rarely even partially achieved as part of natural history in type I SMA infants. No infants in this study achieved a major milestone such as rolling over, or sitting independently, which would therefore represent robust outcomes in future interventional trials.

          Related collections

          Most cited references6

          • Record: found
          • Abstract: found
          • Article: not found

          Optimality score for the neurologic examination of the infant at 12 and 18 months of age.

          The aim of this study was to develop and validate a simple, quantifiable, neurologic examination for infants between 2 and 24 months of age. The assessment consists of 37 items, divided into 3 sections. The first section includes 26 items assessing cranial nerve function, posture, movements, tone, and reflexes; the second section of 8 items documents the development of motor function, and the third section of 3 items evaluates the state of behavior. We applied this assessment to a cohort of ninety-two 12-month-old infants and forty-three 18-month-old infants, with no known perinatal risk factors. The proforma presented has been designed according to the frequency distribution of the neurologic findings in this cohort. Each item is scored individually, and a global score is the sum of all individual scores. The quantitative score enhances the value of this examination, both in clinical practice and in research settings.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Assessment of gross motor development in the WHO Multicentre Growth Reference Study.

            The objective of the Motor Development Study was to describe the acquisition of selected gross motor milestones among affluent children growing up in different cultural settings. This study was conducted in Ghana, India, Norway, Oman, and the United States as part of the longitudinal component of the World Health Organization (WHO) Multicentre Growth Reference Study (MGRS). Infants were followed from the age of four months until they could walk independently. Six milestones that are fundamental to acquiring self-sufficient erect locomotion and are simple to evaluate were assessed: sitting without support, hands-and-knees crawling, standing with assistance, walking with assistance, standing alone, and walking alone. The information was collected by both the children's caregivers and trained MGRS fieldworkers. The caregivers assessed and recorded the dates when the milestones were achieved for the first time according to established criteria. Using standardized procedures, the fieldworkers independently assessed the motor performance of the children and checked parental recording at home visits. To ensure standardized data collection, the sites conducted regular standardization sessions. Data collection and data quality control took place simultaneously. Data verification and cleaning were performed until all queries had been satisfactorily resolved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Spinal muscular atrophy: clinical classification and disease heterogeneity.

              The clinical classification of spinal muscular atrophy, caused by deletion of the survival motor neuron 1 gene (SMN1), is based on age at onset and maximum function achieved. Evidence suggests that maximum function achieved is more closely related to life expectancy than age at onset. Therefore, it is important to wait for a period before assigning a patient to 1 of 5 classes of the disorder. Several diseases result from degeneration of the anterior horn cell but are not caused by SMN1. The classification for these conditions is evolving. This article offers an attempt at organizing one's thinking about this disease group.
                Bookmark

                Author and article information

                Contributors
                Journal
                Neuromuscul Disord
                Neuromuscul. Disord
                Neuromuscular Disorders
                Pergamon Press
                0960-8966
                1873-2364
                1 November 2016
                November 2016
                : 26
                : 11
                : 754-759
                Affiliations
                [a ]Paediatric Neurology Unit, Catholic University and Centro Clinico Nemo, Rome, Italy
                [b ]Department of Neurology, Boston Children's Hospital, Harvard Medical School, Boston, USA
                [c ]Department of Neurology, Columbia University Medical Center, New York, USA
                [d ]Department of Physical Therapy, The Children's Hospital of Philadelphia, Philadelphia, USA
                [e ]Institute of Genetics, Catholic University, Rome, Italy
                [f ]Dubowitz Neuromuscular Centre, UCL Institute of Child Health & Great Ormond Street Hospital, London, UK
                [g ]Nemours Children's Hospital, University of Central Florida College of Medicine, Orlando, USA
                Author notes
                [* ]Corresponding author. Pediatric Neurology, Catholic University, Largo Gemelli 8, 00168 Rome, Italy. Fax: +390630154363.Pediatric NeurologyCatholic UniversityLargo Gemelli 8Rome00168Italy eumercuri@ 123456gmail.com
                Article
                S0960-8966(16)30816-1
                10.1016/j.nmd.2016.10.002
                5091285
                27769560
                a0927a47-d451-4d98-a276-2a61049fde8d
                © 2016 The Authors

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 14 July 2016
                : 17 September 2016
                : 2 October 2016
                Categories
                Article

                Neurology
                spinal muscular atrophy,hammersmith infant neurological examination,outcome measures,motor milestones

                Comments

                Comment on this article